Abstract
In his discussion of McNally's article in Journal of Consulting and Clinical Psychology ( 64, 88–91, 1996), Klein (1996a, Behaviour, Research and Therapy, 34, 849–853) clarifies and further defends his argument that cognitive-behavior therapy (CBT) researchers must incorporate drug and pill placebo conditions in their trial designs and must demonstrate a significant drug effect before they are entitled to make inferences about CBT's antipanic effects. The purpose of this reply is to provide a critique and rebuttal of Klein's arguments.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
